NKTR Long Put Strategy
NKTR (Nektar Therapeutics), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, squamous cell carcinoma of the head and neck, and adjuvant melanoma; phase 2 clinical trial for the treatment of renal cell carcinoma, non-small cell lung cancer, and urothelial cancer; phase 1/2A clinical trial to treat squamous cell carcinoma of the head and neck; phase 1/2 clinical trial for the treatment of solid tumors; and phase 1B clinical trial to treat COVID-19. It is also developing NKTR-358, a cytokine Treg stimulant that is in phase 2 clinical trial for the treatment of systemic lupus erythematosus and ulcerative colitis, as well as phase 1B clinical trial to treat atopic dermatitis and psoriasis; NKTR-255, an IL-15 receptor agonist, which is in phase 1/2 clinical trial for the treatment of non-Hodgkin's lymphoma and multiple myeloma, and head and neck cancer and colorectal cancer; and NKTR-262, a toll-like receptor agonist that is in phase 1/2 clinical trial to treat solid tumors, as well as various other drug candidates. The company has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma S.A.; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; Amgen Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Baxalta Incorporated; Eli Lilly and Company; Merck KGaA; and SFJ Pharmaceuticals, Inc. Nektar Therapeutics was incorporated in 1990 and is headquartered in San Francisco, California.
NKTR (Nektar Therapeutics) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.48B, a beta of 1.25 versus the broader market, a 52-week range of 7.99-109, average daily share volume of 1.1M, a public-listing history dating back to 1994, approximately 61 full-time employees. These structural characteristics shape how NKTR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.25 places NKTR roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a long put on NKTR?
A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.
Current NKTR snapshot
As of May 15, 2026, spot at $70.12, ATM IV 56.90%, IV rank 3.34%, expected move 16.31%. The long put on NKTR below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this long put structure on NKTR specifically: NKTR IV at 56.90% is on the cheap side of its 1-year range, which favors premium-buying structures like a NKTR long put, with a market-implied 1-standard-deviation move of approximately 16.31% (roughly $11.44 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated NKTR expiries trade a higher absolute premium for lower per-day decay. Position sizing on NKTR should anchor to the underlying notional of $70.12 per share and to the trader's directional view on NKTR stock.
NKTR long put setup
The NKTR long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With NKTR near $70.12, the first option leg uses a $70.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed NKTR chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 NKTR shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Put | $70.00 | $4.75 |
NKTR long put risk and reward
- Net Premium / Debit
- -$475.00
- Max Profit (per contract)
- $6,524.00
- Max Loss (per contract)
- -$475.00
- Breakeven(s)
- $65.25
- Risk / Reward Ratio
- 13.735
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.
NKTR long put payoff curve
Modeled P&L at expiration across a range of underlying prices for the long put on NKTR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$6,524.00 |
| $15.51 | -77.9% | +$4,973.72 |
| $31.02 | -55.8% | +$3,423.44 |
| $46.52 | -33.7% | +$1,873.16 |
| $62.02 | -11.5% | +$322.87 |
| $77.52 | +10.6% | -$475.00 |
| $93.03 | +32.7% | -$475.00 |
| $108.53 | +54.8% | -$475.00 |
| $124.03 | +76.9% | -$475.00 |
| $139.54 | +99.0% | -$475.00 |
When traders use long put on NKTR
Long puts on NKTR hedge an existing long NKTR stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying NKTR exposure being hedged.
NKTR thesis for this long put
The market-implied 1-standard-deviation range for NKTR extends from approximately $58.68 on the downside to $81.56 on the upside. A NKTR long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long NKTR position with one put per 100 shares held. Current NKTR IV rank near 3.34% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on NKTR at 56.90%. As a Healthcare name, NKTR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to NKTR-specific events.
NKTR long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. NKTR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move NKTR alongside the broader basket even when NKTR-specific fundamentals are unchanged. Long-premium structures like a long put on NKTR are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current NKTR chain quotes before placing a trade.
Frequently asked questions
- What is a long put on NKTR?
- A long put on NKTR is the long put strategy applied to NKTR (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With NKTR stock trading near $70.12, the strikes shown on this page are snapped to the nearest listed NKTR chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are NKTR long put max profit and max loss calculated?
- Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the NKTR long put priced from the end-of-day chain at a 30-day expiry (ATM IV 56.90%), the computed maximum profit is $6,524.00 per contract and the computed maximum loss is -$475.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a NKTR long put?
- The breakeven for the NKTR long put priced on this page is roughly $65.25 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current NKTR market-implied 1-standard-deviation expected move is approximately 16.31%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long put on NKTR?
- Long puts on NKTR hedge an existing long NKTR stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying NKTR exposure being hedged.
- How does current NKTR implied volatility affect this long put?
- NKTR ATM IV is at 56.90% with IV rank near 3.34%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.